Reporting, access, and transparency : Better infrastructure of clinical trials
Identifieur interne :
000068 ( PascalFrancis/Corpus );
précédent :
000067;
suivant :
000069
Reporting, access, and transparency : Better infrastructure of clinical trials
Auteurs : Massimo Antonelli ;
Giovanna MercurioSource :
-
Critical care medicine [ 0090-3493 ] ; 2009.
RBID : Pascal:09-0069946
Descripteurs français
English descriptors
Abstract
Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0090-3493 |
|---|
| A02 | 01 | | | @0 CCMDC7 |
|---|
| A03 | | 1 | | @0 Crit. care med. |
|---|
| A05 | | | | @2 37 |
|---|
| A06 | | | | @2 1 @3 SUP |
|---|
| A08 | 01 | 1 | ENG | @1 Reporting, access, and transparency : Better infrastructure of clinical trials |
|---|
| A09 | 01 | 1 | ENG | @1 Improving Clinical Trials in the Critically Ill: Proceedings of a Roundtable Conference in Brussels, Belgium, March 2008 |
|---|
| A11 | 01 | 1 | | @1 ANTONELLI (Massimo) |
|---|
| A11 | 02 | 1 | | @1 MERCURIO (Giovanna) |
|---|
| A12 | 01 | 1 | | @1 ANGUS (Derek C.) @9 ed. |
|---|
| A12 | 02 | 1 | | @1 MIRA (Jean-Paul) @9 ed. |
|---|
| A14 | 01 | | | @1 Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore @2 Rome @3 ITA @Z 1 aut. @Z 2 aut. |
|---|
| A15 | 01 | | | @1 CRISMA Laboratory, Department of Critical Care medicine, University of Pittsburgh @2 Pittsburgh, PA @3 USA @Z 1 aut. |
|---|
| A20 | | | | @2 S178-S183 |
|---|
| A21 | | | | @1 2009 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 17751 @5 354000184061330250 |
|---|
| A44 | | | | @0 0000 @1 © 2009 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 43 ref. |
|---|
| A47 | 01 | 1 | | @0 09-0069946 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Critical care medicine |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C01 | 01 | | ENG | @0 Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science. |
|---|
| C02 | 01 | X | | @0 002B27B |
|---|
| C02 | 02 | X | | @0 002B02A06 |
|---|
| C03 | 01 | X | FRE | @0 Industrie @5 09 |
|---|
| C03 | 01 | X | ENG | @0 Industry @5 09 |
|---|
| C03 | 01 | X | SPA | @0 Industria @5 09 |
|---|
| C03 | 02 | X | FRE | @0 Réanimation @5 10 |
|---|
| C03 | 02 | X | ENG | @0 Resuscitation @5 10 |
|---|
| C03 | 02 | X | SPA | @0 Reanimación @5 10 |
|---|
| C03 | 03 | X | FRE | @0 Soin intensif @5 11 |
|---|
| C03 | 03 | X | ENG | @0 Intensive care @5 11 |
|---|
| C03 | 03 | X | SPA | @0 Cuidado intensivo @5 11 |
|---|
| N21 | | | | @1 054 |
|---|
| N44 | 01 | | | @1 OTO |
|---|
| N82 | | | | @1 OTO |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Improving Clinical Trials in the Critically Ill: Proceedings of a Roundtable Conference @3 Brussels BEL @4 2008-03 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 09-0069946 INIST |
|---|
| ET : | Reporting, access, and transparency : Better infrastructure of clinical trials |
|---|
| AU : | ANTONELLI (Massimo); MERCURIO (Giovanna); ANGUS (Derek C.); MIRA (Jean-Paul) |
|---|
| AF : | Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore/Rome/Italie (1 aut., 2 aut.); CRISMA Laboratory, Department of Critical Care medicine, University of Pittsburgh/Pittsburgh, PA/Etats-Unis (1 aut.) |
|---|
| DT : | Publication en série; Congrès; Niveau analytique |
|---|
| SO : | Critical care medicine; ISSN 0090-3493; Coden CCMDC7; Etats-Unis; Da. 2009; Vol. 37; No. 1 SUP; S178-S183; Bibl. 43 ref. |
|---|
| LA : | Anglais |
|---|
| EA : | Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science. |
|---|
| CC : | 002B27B; 002B02A06 |
|---|
| FD : | Industrie; Réanimation; Soin intensif |
|---|
| ED : | Industry; Resuscitation; Intensive care |
|---|
| SD : | Industria; Reanimación; Cuidado intensivo |
|---|
| LO : | INIST-17751.354000184061330250 |
|---|
| ID : | 09-0069946 |
|---|
Links to Exploration step
Pascal:09-0069946
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Reporting, access, and transparency : Better infrastructure of clinical trials</title>
<author><name sortKey="Antonelli, Massimo" sort="Antonelli, Massimo" uniqKey="Antonelli M" first="Massimo" last="Antonelli">Massimo Antonelli</name>
<affiliation><inist:fA14 i1="01"><s1>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Mercurio, Giovanna" sort="Mercurio, Giovanna" uniqKey="Mercurio G" first="Giovanna" last="Mercurio">Giovanna Mercurio</name>
<affiliation><inist:fA14 i1="01"><s1>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0069946</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0069946 INIST</idno>
<idno type="RBID">Pascal:09-0069946</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000068</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Reporting, access, and transparency : Better infrastructure of clinical trials</title>
<author><name sortKey="Antonelli, Massimo" sort="Antonelli, Massimo" uniqKey="Antonelli M" first="Massimo" last="Antonelli">Massimo Antonelli</name>
<affiliation><inist:fA14 i1="01"><s1>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Mercurio, Giovanna" sort="Mercurio, Giovanna" uniqKey="Mercurio G" first="Giovanna" last="Mercurio">Giovanna Mercurio</name>
<affiliation><inist:fA14 i1="01"><s1>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><series><title level="j" type="main">Critical care medicine</title>
<title level="j" type="abbreviated">Crit. care med.</title>
<idno type="ISSN">0090-3493</idno>
<imprint><date when="2009">2009</date>
</imprint><seriesStmt><title level="j" type="main">Critical care medicine</title>
<title level="j" type="abbreviated">Crit. care med.</title>
<idno type="ISSN">0090-3493</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Industry</term>
<term>Intensive care</term>
<term>Resuscitation</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Industrie</term>
<term>Réanimation</term>
<term>Soin intensif</term>
</keywords><front><div type="abstract" xml:lang="en">Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0090-3493</s0>
</fA01><fA02 i1="01"><s0>CCMDC7</s0>
</fA02><fA03 i2="1"><s0>Crit. care med.</s0>
</fA03><fA06><s2>1</s2>
<s3>SUP</s3>
</fA06><fA08 i1="01" i2="1" l="ENG"><s1>Reporting, access, and transparency : Better infrastructure of clinical trials</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Improving Clinical Trials in the Critically Ill: Proceedings of a Roundtable Conference in Brussels, Belgium, March 2008</s1>
</fA09><fA11 i1="01" i2="1"><s1>ANTONELLI (Massimo)</s1>
</fA11><fA11 i1="02" i2="1"><s1>MERCURIO (Giovanna)</s1>
</fA11><fA12 i1="01" i2="1"><s1>ANGUS (Derek C.)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="02" i2="1"><s1>MIRA (Jean-Paul)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14><fA15 i1="01"><s1>CRISMA Laboratory, Department of Critical Care medicine, University of Pittsburgh</s1>
<s2>Pittsburgh, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15><fA20><s2>S178-S183</s2>
</fA20><fA21><s1>2009</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>17751</s2>
<s5>354000184061330250</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>43 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>09-0069946</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Critical care medicine</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC01 i1="01" l="ENG"><s0>Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B27B</s0>
</fC02><fC02 i1="02" i2="X"><s0>002B02A06</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Industrie</s0>
<s5>09</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Industry</s0>
<s5>09</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Industria</s0>
<s5>09</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Réanimation</s0>
<s5>10</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Resuscitation</s0>
<s5>10</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Reanimación</s0>
<s5>10</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Soin intensif</s0>
<s5>11</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Intensive care</s0>
<s5>11</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Cuidado intensivo</s0>
<s5>11</s5>
</fC03><fN21><s1>054</s1>
</fN21><fN44 i1="01"><s1>OTO</s1>
</fN44><fN82><s1>OTO</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Improving Clinical Trials in the Critically Ill: Proceedings of a Roundtable Conference</s1>
<s3>Brussels BEL</s3>
<s4>2008-03</s4>
</fA30><server><NO>PASCAL 09-0069946 INIST</NO>
<ET>Reporting, access, and transparency : Better infrastructure of clinical trials</ET>
<AU>ANTONELLI (Massimo); MERCURIO (Giovanna); ANGUS (Derek C.); MIRA (Jean-Paul)</AU>
<AF>Istituto di Anestesiologia e Rianimazione, Policlinico Universitario A.Gemelli, Università Cattolica del Sacro Cuore/Rome/Italie (1 aut., 2 aut.); CRISMA Laboratory, Department of Critical Care medicine, University of Pittsburgh/Pittsburgh, PA/Etats-Unis (1 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Critical care medicine; ISSN 0090-3493; Coden CCMDC7; Etats-Unis; Da. 2009; Vol. 37; No. 1 SUP; S178-S183; Bibl. 43 ref.</SO>
<LA>Anglais</LA>
<EA>Open access to information in medical science and adequate reporting of clinical trials may allow investigators and editors to recognize bias in study designs and avoid unnecessary duplication of efforts. Unfortunately, most of clinical trials are very expensive and are often supported by industries that may have financial reasons to hide or partially disclose results. However, investigators and editors have a greater interest in publishing results that can immediately change clinical practice rather than negative results, thus contributing to facilitate publication biases. Several years ago, legislation in several countries mandated the registration of clinical trials as an effective means of promoting information access and full transparency in medical research. However, comprehensive registers have not been adequately supported by law, particularly in Europe, where legislation has ironically contributed to fragmented research, and dampened its competitiveness and productivity. In this context, appropriate strategies help to protect the independence of academic research and ensure full transparency in medical science.</EA>
<CC>002B27B; 002B02A06</CC>
<FD>Industrie; Réanimation; Soin intensif</FD>
<ED>Industry; Resuscitation; Intensive care</ED>
<SD>Industria; Reanimación; Cuidado intensivo</SD>
<LO>INIST-17751.354000184061330250</LO>
<ID>09-0069946</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000068 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000068 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:09-0069946
|texte= Reporting, access, and transparency : Better infrastructure of clinical trials
}}
| This area was generated with Dilib version V0.6.25.
Data generation: Thu Dec 1 00:43:49 2016. Site generation: Wed Mar 6 14:51:30 2024 |  |
